XENETIC BIOSCIENCES, INC. Preferred Stock, Value, Issued
XENETIC BIOSCIENCES, INC. (XBIO) had Preferred Stock, Value, Issued of $2.77 thousand as of 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2021-05-11
- 2021-03-31: Preferred Stock, Value, Issued $2.77K.
- 2020-12-31: Preferred Stock, Value, Issued $2.77K.
- 2016-09-30: Preferred Stock, Value, Issued $970.00.
- 2015-12-31: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2021-03-31 | $2.77K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.77K 10-Q · filed 2021-05-11 |
| 2016-09-30 | $970.00 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |